What Rommelag does

Rommelag is a German manufacturer and service provider headquartered in Sulzbach-Laufen, and is identified as the inventor of Blow-Fill-Seal (BFS) aseptic packaging technology. BFS is a continuous closed-system process in which plastic containers are extruded, blow-molded, aseptically filled, and sealed inside a single machine, eliminating human intervention in the sterile zone and supporting high-throughput aseptic fill of liquids, ophthalmics, injectables, and topical products. The company's flagship equipment line is the bottelpack machine family, supplemented by multi-layer container technology for products requiring enhanced oxygen or moisture barrier properties. End markets are dominated by pharmaceutical manufacturers, with secondary application in cosmetics and chemicals.

Rommelag operates a hybrid equipment-plus-services business model. Capital equipment revenue is generated through new bottelpack machine sales, pre-owned machine resale, and modernization/upgrade projects. A CDMO (Contract Development and Manufacturing Organization) arm performs clinical and commercial aseptic fill-finish on Rommelag-owned machines, both as a standalone service and as a customer-acquisition channel for equipment sales. Complementary service lines include Rommelag Pharma Service (RPS) for FDA and EU-GMP qualification and validation under a Fast Track Concept, after-sales support, operator training, and the Machine Hub digital platform for fleet monitoring and process digitalization. The installed base exceeds 15,000 BFS machines globally, supporting recurring parts and service annuities.

Go-to-market targets regulated enterprise pharmaceutical customers through long direct-sales cycles, qualification-led purchasing, and multi-year service contracts. Rommelag monetizes across the equipment lifecycle — initial sale, recurring parts and service, modernization upgrades, CDMO fees, and digital subscriptions — producing a multi-stream revenue profile anchored in regulated end markets. Global presence is delivered through regional sales and service offices, including operations in China, supported by a multilingual digital presence. The combined equipment-plus-CDMO-plus-regulatory-service model is the company's core commercial differentiator against pure-play equipment vendors and pure-play aseptic CDMOs.

Name

Rommelag

Legal name

Rommelag SE & Co. KG

Website

https://rommelag.com

Company type

Private

Founded year

1952

Operating status

Operating

Headcount range

51–100 employees

Short description

Rommelag is the German inventor of Blow-Fill-Seal aseptic packaging technology, headquartered in Sulzbach-Laufen. It sells bottelpack BFS machines and provides CDMO, qualification, modernization, and digital services primarily to pharmaceutical manufacturers worldwide.

Ownership category

akta.pro rank

Product category

Aseptic Pharmaceutical Packaging Equipment

NAICS

Packaging Machinery Manufacturing (333993)

akta.pro primary industry

Filling & Dosing Equipment (Liquid, Powder, Aseptic) (IMALAOAB)

akta.pro secondary industries

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Filling & Dosing Machines (Liquid/Powder/Solid) (IMAHAOAF)

Keywords

• Aseptic filling machines
• Blow-fill-seal technology
• Pharmaceutical packaging equipment
• Contract manufacturing services
• Sterile packaging solutions

Headquarters

HQ city

Aarau

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Bottelpack Machine Sales: Sale of Blow-Fill-Seal equipment and filling machines. Machines are available new or as pre-owned refurbished units.
2. CDMO Contract Manufacturing: Contract filling and development services for companies wanting to use BFS technology without large capital investment. Provides modern facilities and comprehensive service packages at competitive prices.
3. After-Sales Services: Comprehensive post-sale support including commissioning, training, service agreements, inspection, remote maintenance, spare parts, and repairs. Service agreements offer modular services from technical support to full-service solutions.
4. Modernization and Upgrades: Retrofit solutions, upgrades, and modernization packages for existing bottelpack machines to extend equipment life and improve efficiency.
5. Pre-Owned Machines: Sale of refurbished used bottelpack machines with comprehensive overhaul, quality inspection, and individual customization options.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Rommelag manufactures and sells bottelpack aseptic filling machines built on its proprietary Blow-Fill-Seal (BFS) technology, which forms, fills, and seals unbreakable polymer containers in a single fully automated aseptic process at speeds up to 37,500 containers per hour. The company complements its equipment business with CDMO contract filling and product development services, qualification and validation support (Rommelag Pharma Service), after-sales service agreements, modernization/upgrade retrofits, the Machine Hub digital platform, and pre-owned refurbished bottelpack machines for pharmaceutical, cosmetics, and chemical customers worldwide.

Product overview

Rommelag is a German pharmaceutical packaging company and the inventor of Blow-Fill-Seal (BFS) technology, operating as both a machine manufacturer and contract development and manufacturing organization (CDMO). The company's product portfolio centers on bottelpack filling machines that utilize BFS technology to produce unbreakable polymer containers in a fully automated aseptic process, capable of speeds up to 37,500 containers per hour. Rommelag complements its core manufacturing business with comprehensive services including contract filling (CDMO), qualification and validation (RPS), after-sales support, machine modernization and upgrades, pre-owned equipment sales, digitalization solutions (including the proprietary Machine Hub platform), and factory planning services. The company serves the pharmaceutical, chemical, and cosmetics industries.

Differentiator

Problem solved

Functional benefit

Brands

• bottelpack: Brand name for Rommelag's BFS filling machines that produce unbreakable polymer containers using blow-fill-seal technology. bottelpack machines can produce up to 37,500 BFS containers per hour.
• Rommelag FLEX
• Rommelag Pharma Service (RPS)

Products and services

• bottelpack Aseptic Filling Machines Aseptic filling machines using Blow-Fill-Seal technology that produce unbreakable polymer containers. bottelpack machines can produce up to 37,500 BFS containers per hour and are the most space-efficient aseptic filling systems on the market. Targeted at pharmaceutical, cosmetics, and chemical manufacturers requiring sterile packaging.
• Rommelag FLEX CDMO Contract Filling and Development Services Contract development and manufacturing organization (CDMO) services providing BFS-based contract filling, product development support, and production capacity for companies that want to test BFS technology without major capital investment, cover production peaks, or outsource full market batches.
• Rommelag Pharma Service (RPS) Qualification and Validation Modular qualification and validation concept for bottelpack machine installations, offered in Silver (free templates), Gold (qualification consultation), and Platinum (full qualification execution) packages, with a Fast Track Concept that can reduce qualification process duration by up to 40%.
• After-Sales Services Post-sale services for bottelpack machines including commissioning, training, modular service agreements, inspection, remote maintenance, spare parts, and repairs, delivered through Rommelag's global service network with 24/7 expert availability.
• Modernization and Upgrades (Retrofit Solutions) Retrofit solutions, upgrades, and modernization services for existing bottelpack machines to improve product quality, extend equipment lifespan, meet regulatory requirements, and adapt to new production demands.
• Pre-Owned Refurbished bottelpack Machines Refurbished used bottelpack machines with short delivery times and low investment cost, meeting pharmaceutical industry requirements and FDA, ANVISA, and ABRASP standards, offered as a lower-cost entry option for BFS technology.
• Digitalization Solutions (including Machine Hub) Digital services and the proprietary Machine Hub data and communication platform that enable digitalization, system networking, and remote monitoring of BFS production lines.
• Factory Planning and Production Optimization Consulting and engineering services for planning, expansion, reorganization, and optimization of BFS production facilities.

Quantifiable outcome

• Up to 37,500 BFS containers per hour production rate
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Recipharm: Recipharm is a global CDMO offering sterile fill-finish and other aseptic manufacturing services to pharmaceutical customers. It competes with Rommelag Flex for contract filling of liquid and semi-solid sterile products across pharma and ophthalmics.
• Vetter Pharma: Vetter Pharma is a specialist CDMO focused on aseptic fill-finish of injectables, including complex packaging formats. It is comparable to Rommelag's Rommelag Flex CDMO business in serving pharma customers that want to outsource sterile liquid filling rather than buy their own equipment.
• Catalent: Catalent is identified as a leading competitor in the BFS equipment market and is also one of the world's largest CDMOs with extensive sterile fill-finish capacity. It overlaps Rommelag across both the bottelpack machine line and the contract manufacturing service line, especially for ophthalmic and respiratory unit-dose products.
• Brevetti Angela: Brevetti Angela is an Italian manufacturer of Blow-Fill-Seal aseptic filling machines serving pharmaceutical and cosmetic customers. It is a focused BFS peer with overlapping technology, customer verticals, and geographic reach in Europe and emerging markets.
• Syntegon: Syntegon (formerly Bosch Packaging Technology) is a leading global supplier of aseptic filling and packaging machinery, including BFS, vial, and syringe systems. It competes head-to-head with Rommelag's bottelpack machines across the same pharmaceutical customers and CDMO buyer set.
• Weiler Engineering: Weiler Engineering is a US-based manufacturer of aseptic BFS packaging machinery for pharmaceutical and healthcare applications. It directly competes with Rommelag's bottelpack line in the same aseptic fill-finish equipment category, particularly serving North American pharma customers.

Others

• Lonza: Lonza is one of the world's largest biologics CDMOs with extensive fill-finish capacity. While broader and biologics-focused rather than a BFS specialist, it overlaps with Rommelag's CDMO offering for sterile liquid drug product manufacturing serving global pharma.

Broad incumbents

• Patheon (Thermo Fisher Scientific): Patheon, now part of Thermo Fisher Scientific's pharma services division, is a large CDMO with sterile fill-finish capabilities. It is comparable to Rommelag Flex as an outsourced sterile manufacturing option for pharmaceutical customers, though it operates at significantly larger scale and scope.
• GEA Group: GEA Group is identified as a leading player in BFS equipment alongside Rommelag, but as a much larger diversified industrial machinery group its BFS offering sits within a broad portfolio of process and packaging equipment serving food, dairy, and pharma.
• Becton Dickinson (BD): BD operates a pharmaceutical systems business that includes aseptic packaging and unit-dose drug delivery formats. It is an adjacent incumbent in aseptic primary packaging for pharma, competing for the same applications (ophthalmic, respiratory, injectable unit-dose) where Rommelag's BFS machines are strong.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/rommelag
• TikToktiktok.com/@rommelag
• LinkedInlinkedin.com/company/rommelag
• YouTubeyoutube.com/rommelag

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rommelag